A review of prostate cancer in 2021
1 December 2021

A review of prostate cancer in 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer in 2021
  • Discuss how the new data will affect and be integrated into daily clinical practice.

 

Faculty:

  • Heather Payne (UK)
  • Kurt Miller (Germany)
  • Piet Ost (Belgium)
  • Maria de Santis (Germany)
  • Aurelius Omlin (Switzerland)
more info...

EM-78554
Experts’ views on bladder cancer news from 2021
2 December 2021

Experts’ views on bladder cancer news from 2021

An exciting programme with all the major advances in bladder cancer from 2021 is under development by the Scientific Committee, Professor Alison Birtle and Professor Ignacio Durán. Mark the date in your calendar to join the expert faculty in discussing the year in bladder cancer!

 

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss ...

more info...

EM-77678
EGFR+ NSCLC in 2021: Key highlights of the year
15 December 2021

EGFR+ NSCLC in 2021: Key highlights of the year

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe key data on the diagnosis and management of patients with EGFR-positive NSCLC from 2021
  • Contextualise key learnings from 2021 into clinical practice through case study discussion and evaluation

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

more info...

EM-60991
Understanding the data from the Advanced Prostate Cancer Consensus Conference (APCCC) 2021
12 October 2021 - 90 Minutes

Understanding the data from the Advanced Prostate Cancer Consensus Conference (APCCC) 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain new data on prostate cancer from APCCC 2021
  • Discuss how these new data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Alberto Bossi (France)
  • Robert Jones (UK)
  • ...

more info...

EM-67612
Advances in the management of men with prostate cancer: Reflections on the last decade and perspectives for the future
3 October 2021 - 90 Minutes

Advances in the management of men with prostate cancer: Reflections on the last decade and perspectives for the future

On demand Janssen satellite symposium from the virtual ESMO Congress 2021

In the last 10 years, important advancements in the treatment and management of patients with advanced prostate cancer were implemented in daily clinical practice. It is now the right time to reflect on what was achieved and to discuss the focus and development of management and new treatment options for men with prostate cancer in the years to come.

This ...

more info...

EM-67449
Expanding horizons for the targeted management of EGFR-positive NSCLC
2 October 2021 - 92 Minutes

Expanding horizons for the targeted management of EGFR-positive NSCLC

On demand Janssen satellite symposium from the virtual ESMO Congress 2021

Video recording by the congress organisers of the Janssen Symposium from the ESMO Congress 2021 that took place on 18 September.

Learning objective:         

After watching this broadcast, participants should be able to:

  • Reflect on novel management paradigms for patients with EGFR+ NSCLC, who are resistant to EGFR targeted therapies
  • Evaluate new and emerging diagnostic ...
more info...

EM-67433
Experts’ views on bladder cancer news from September 2021
28 September 2021 - 57 Minutes

Experts’ views on bladder cancer news from September 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain new data in bladder cancer from September 2021
  • Integrate the new data into the current disease landscape and discuss how these will affect clinical practice

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Duran (Spain)
  • Maria De Santis (Germany)
  • Fred Witjes ...

more info...

EM-67608
Charting the landscape for EGFR-positive NSCLC
24 September 2021 - 60 Minutes

Charting the landscape for EGFR-positive NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate novel data in molecular testing for EGFR+ NSCLC
  • Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

 

Faculty:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
  • Reinhard Büttner (Germany)
  • Sanjay Popat ...

more info...

EM-69921
Experts’ views on prostate cancer news from September 2021
23 September 2021 - 58 Minutes

Experts’ views on prostate cancer news from September 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the recent data on prostate cancer from September 2021
  • Discuss how these recent data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Stephane Oudard (France)
  • Eleni Efstathiou (USA)
more info...

EM-67614
Are we doing enough? Navigating the changing landscape of mHSPC
9 July 2021 - 63 Minutes

Are we doing enough? Navigating the changing landscape of mHSPC

Janssen sponsored Industry Session at the EAU 2021 Virtual Congress

 

Learning objective:         

After watching this broadcast, participants should be able to:

  • Understand advances in therapeutic options in mHSPC and their impact on clinical practice
  • Re-evaluate current clinical decision making and define best practice approaches to individualised care for patients with mHSPC

 

Scientific Committee:

more info...

EM-62327
;